Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spannagl

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
The British Journal of Dermatology|January 1, 1997
Urticaria haemorrhagica profundaA Wollenberg, S Hänel, M Spannagl, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Development of a chromogenic substrate assay for the determination of hirudin in plasmaM Spannagl, J Bichler, A Birg, et al.
Der Anaesthesist|February 4, 2009
[Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin]M Angstwurm, J Hoffmann, H Ostermann, et al.
Hamostaseologie|November 11, 2014
Climbing therapy under PK-tailored prophylaxisM Stemberger, E Schmit, D Czepa, et al.
The Journal of Trauma|November 1, 1994
Delayed treatment with platelet activating factor receptor antagonist web 2086 attenuates pulmonary dysfunction in porcine endotoxin shockM Siebeck, J Kohl, S Endres, et al.
Gastroenterology|July 31, 1999
Factor V Leiden mutation in patients with inflammatory bowel diseaseM Spannagl, A Dick, C Folwaczny, et al.
Thrombosis Research|September 1, 1991
The nitric oxide donor SIN-1 is a potent inhibitor of plasminogen activator inhibitor release from stimulated plateletsC Drummer, S Lüdke, M Spannagl, et al.
Clinical Laboratory|October 9, 2014
Measurement procedure for glucose in serum using liquid chromatography isotope dilution--tandem mass spectrometry (LC-ID-MS/MS)M Kress, D Meissner, U Kramer, et al.
Seminars in Thrombosis and Hemostasis|December 2, 1998
Resistance to activated protein C in women using oral contraceptivesM Spannagl, A Dick, A Assmann, et al.
Deutsche Medizinische Wochenschrift (1946)|January 29, 2000
[The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results]W Schramm, L A Heinemann, M Spannagl, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
The British Journal of Dermatology|January 1, 1997
Urticaria haemorrhagica profundaA Wollenberg, S Hänel, M Spannagl, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Development of a chromogenic substrate assay for the determination of hirudin in plasmaM Spannagl, J Bichler, A Birg, et al.
Der Anaesthesist|February 4, 2009
[Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin]M Angstwurm, J Hoffmann, H Ostermann, et al.
Hamostaseologie|November 11, 2014
Climbing therapy under PK-tailored prophylaxisM Stemberger, E Schmit, D Czepa, et al.
The Journal of Trauma|November 1, 1994
Delayed treatment with platelet activating factor receptor antagonist web 2086 attenuates pulmonary dysfunction in porcine endotoxin shockM Siebeck, J Kohl, S Endres, et al.
Gastroenterology|July 31, 1999
Factor V Leiden mutation in patients with inflammatory bowel diseaseM Spannagl, A Dick, C Folwaczny, et al.
Thrombosis Research|September 1, 1991
The nitric oxide donor SIN-1 is a potent inhibitor of plasminogen activator inhibitor release from stimulated plateletsC Drummer, S Lüdke, M Spannagl, et al.
Clinical Laboratory|October 9, 2014
Measurement procedure for glucose in serum using liquid chromatography isotope dilution--tandem mass spectrometry (LC-ID-MS/MS)M Kress, D Meissner, U Kramer, et al.
Seminars in Thrombosis and Hemostasis|December 2, 1998
Resistance to activated protein C in women using oral contraceptivesM Spannagl, A Dick, A Assmann, et al.
Deutsche Medizinische Wochenschrift (1946)|January 29, 2000
[The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results]W Schramm, L A Heinemann, M Spannagl, et al.
Pageof 13